← 홈

전체 프로그램

ADC 1032 · Antibody 4684 · CGT 2713 · 다음 갱신 D-14 · 마지막 7월 31일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,531개
ADCBiologicstaleShanghai Henlius BiotechPhase 1

HLX42 (HLX42)

Solid Tumor and NSCLC · Solid Tumor and NSCLC

#SolidTumorandNSCLC#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleShanghai Henlius BiotechPhase 2

HLX43 DOSE1 IN 1L TNBC (HLX43 DOSE1 IN 1L TNBC)

Breast Cancer (Triple Negative Breast Cancer (TNBC)) · Breast Cancer (Triple Negative Breast Ca

#BreastCancerTripleNegativeBreast#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleShanghai Henlius BiotechPhase 1

HLX48 (HLX48)

Advanced/Metastatic Solid Tumors · Advanced/Metastatic Solid Tumors

#AdvancedMetastaticSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleShanghai Henlius BiotechPhase 3

HLX87+HX22 (HLX87+HX22)

HER2 + Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleHanmi Pharmaceutical Company Li…Phase 1

HM95573, cetuximab (HM95573, cetuximab)

Locally Advanced Solid Tumor; Metastatic Solid Tumor · Locally Advanced Solid Tumor

#LocallyAdvancedSolidTumor#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleChang Gung Memorial HospitalPreclinical

nivolumab (Opdivo, HNSCC patients have used Nivolumab)

HNSCC · HNSCC

#HNSCC#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
CGTBiologicstaleTCRCure Biopharma Ltd.Phase 1

HPV E6-specific TCR-T cells (HPV E6-specific TCR-T cells)

Cervical Cancer; Head and Neck Squamous Cell Carcinoma · Cervical Cancer

#CervicalCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab (HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 3

HR070803 simulator plus oxaliplatin, 5-FU/LV, bevacizumab (HR070803 simulator plus oxaliplatin, 5-FU/LV, bevacizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
ADCBiologicstaleFudan UniversityPhase 2

HRS-4508 (HRS-4508)

Breast Neoplasm; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

HRS-7058 + Cetuximab (HRS-7058 + Cetuximab)

Advanced Malignant Tumour · Advanced Malignant Tumour

#AdvancedMalignantTumour#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
ADCBiologicstaleShandong Suncadia Medicine Co.,…Phase 2

HRS-7058 + SHR-A1202 (HRS-7058 + SHR-A1202)

Advanced Malignant Tumour · Advanced Malignant Tumour

#AdvancedMalignantTumour#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleShandong Suncadia Medicine Co.,…Phase 2

HRS-7058 +SHR-A2102 +BP102 (HRS-7058 +SHR-A2102 +BP102)

Advanced Malignant Tumour · Advanced Malignant Tumour

#AdvancedMalignantTumour#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleShandong Suncadia Medicine Co.,…Phase 2

HRS-7058 +SHR-A2102 +SHR-1316 (HRS-7058 +SHR-A2102 +SHR-1316)

Advanced Malignant Tumour · Advanced Malignant Tumour

#AdvancedMalignantTumour#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleShandong Suncadia Medicine Co.,…Phase 2

HRS-7058 +SHR-A2102 +SHR-1316 +BP102 (HRS-7058 +SHR-A2102 +SHR-1316 +BP102)

Advanced Malignant Tumour · Advanced Malignant Tumour

#AdvancedMalignantTumour#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
AntibodystaleCancer Research UKPhase 2

atezolizumab (Tecentriq, HTL0039732 Capsules and atezolizumab infusion)

Neoplasms; Prostatic Neoplasms, Castration-Resistant · Neoplasms

#Neoplasms#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
ADCBiologicstaleWhitehawk Therapeutics, Inc.Phase 1

HWK-007 (HWK-007)

Endometrial Cancer; Ovarian Cancer · EGFR

#EGFR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleWhitehawk Therapeutics, Inc.Phase 1

HWK-016, MUCIN-16-targeted ADC (HWK-016, MUCIN-16-targeted ADC)

PROC; Platinum Resistant Ovarian Cancer · PROC

#PROC#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleTaizhou Hanzhong biomedical co.…Phase 3

Pucotenlimab (HX008, HX008(Pucotenlimab))

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleFudan UniversityPhase 2

trastuzumab (Herceptin, HX008，Niraparib，Trastuzumab)

Treatment Efficacy · Treatment Efficacy

#TreatmentEfficacy#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE

120 / 177 페이지

← 이전다음 →